Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000203949 | SCV000262510 | benign | Primary ciliary dyskinesia | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000244070 | SCV000307563 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002503820 | SCV002813734 | likely benign | Primary ciliary dyskinesia 7 | 2022-05-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002503820 | SCV003799466 | benign | Primary ciliary dyskinesia 7 | 2024-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000203949 | SCV004848990 | likely benign | Primary ciliary dyskinesia | 2016-01-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |